Efforts to optimize treatments to address critical challenges in treating idiopathic pulmonary fibrosis (IPF)…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Inflammatory bowel disease (IBD) increases the risk of developing idiopathic…
The natural product tannic acid has anti-fibrotic effects on cultured human lung fibroblasts and in an…
The Pulmonary Fibrosis Foundation (PFF) announced that its nationwide Care Center Network (CCN)…